Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment.
- DOI
- 10.1186/s40425-018-0403-1
- Published
- 2018 Oct 11
- Container
- Journal for immunotherapy of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s40425-018-0403-1,
title = {Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment.},
author = {Tada Y and Togashi Y and Kotani D and Kuwata T and Sato E and Kawazoe A and Doi T and Wada H and Nishikawa H and Shitara K},
year = {2018},
journal = {Journal for immunotherapy of cancer},
doi = {10.1186/s40425-018-0403-1},
url = {https://doi.org/10.1186/s40425-018-0403-1}
}RIS
TY - JOUR TI - Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment. AU - Tada Y AU - Togashi Y AU - Kotani D AU - Kuwata T AU - Sato E AU - Kawazoe A AU - Doi T AU - Wada H AU - Nishikawa H AU - Shitara K PY - 2018 JO - Journal for immunotherapy of cancer DO - 10.1186/s40425-018-0403-1 UR - https://doi.org/10.1186/s40425-018-0403-1 ER -
APA
Y, T., Y, T., D, K., T, K., E, S., A, K., T, D., H, W., H, N., & K, S. (2018). Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment.. Journal for immunotherapy of cancer. https://doi.org/10.1186/s40425-018-0403-1
Source records
- pubmed · retrieved 2026-09-26T07:54:45.528Z